The global tricuspid valve repair market is expected to grow at a CAGR of 9.33% from 2020 to reach USD 180.75 million by 2030. The growth is primarily attributed to technological advancements, rising geriatric population, prevalence of valvular cardiac defects, strengthening of computational tools to regulate pressure changes, rising demand for minimally invasive heart surgeries, risks associated with open heart surgeries and unavailability of medical devices for treating tricuspid valves. However, high risk of complications in tricuspid valve surgeries and lack of efficient healthcare infrastructure can pose significant challenge to the growth of this market.
The global tricuspid valve repair market study provides market data for-by product type (Tricuspid atresia repair, Tricuspid regurgitation repair, Tricuspid valve depression deformity repair, Others), by end user (hospitals, ambulatory surgical centre, cardiac catheterization laboratories). The study also evaluates industry competitors and analyses the market at a regional and country level.
Replacement segment dominated the tricuspid valve repair market in 2020. Large market share of this segment can be attributed to increasing number of valve replacement surgeries, favourable reimbursement scenarios, technological advancements and rising prevalence of valve diseases.
By End user, Hospital segment accounted for the largest share of tricuspid valve repair market in the forecast period. The large share of this segment is mainly driven by technologically advanced medical devices, highly qualified professionals and rising number of hospitals are responsible to drive the growth of this market segment.
This research report analyses major geographies and provides a comprehensive analysis of North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, India, Japan, and RoAPAC), Rest of the world (Latin America, and Middle East & Africa). North America accounted for the largest share of the global tricuspid valve repair market. The large share of this market is attributed to rampant adoption of tricuspid valve repair surgeries, rising obese population, prevalence of lifestyle disorders and technological advancements. APAC is expected to grow at the highest rate due to rising geriatric population, improving healthcare infrastructure, government initiatives and rapid adoption of tissue valves.
The major players operating in the global Tricuspid valve repair market are
- Abbott Technologies Inc.
- Medtronic Plc
- Edwards Lifescience Corporation
- Livanova
- and others.
The Tricuspid Valve Repair Market witnessed a decline in the growth due to COVID-19 pandemic as more emphasis was put on covid infection and hospitals were unavailable for other patients. The surgeries were postponed and patients were advised not to visit infected areas. However, the growth was expected to quickly rebound by first half of 2021. Any appearances of concerning mutants of COVID-19 can halt the growth of this market but is expected to quickly rebound to pre-COVID levels.